- Home
- AUPH vs VTEX Comparison
AUPH vs VTEX Comparison
Compare AUPH & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- VTEX
- Stock Information
- Founded
- AUPH 1993
- VTEX 1999
- Country
- AUPH Canada
- VTEX Cayman Islands
- Employees
- AUPH N/A
- VTEX N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- VTEX Computer Software: Prepackaged Software
- Sector
- AUPH Health Care
- VTEX Technology
- Exchange
- AUPH Nasdaq
- VTEX Nasdaq
- Market Cap
- AUPH 999.8M
- VTEX 979.0M
- IPO Year
- AUPH 1999
- VTEX 2021
- Fundamental
- Price
- AUPH $7.85
- VTEX $6.42
- Analyst Decision
- AUPH Strong Buy
- VTEX Strong Buy
- Analyst Count
- AUPH 2
- VTEX 2
- Target Price
- AUPH $11.50
- VTEX $8.75
- AVG Volume (30 Days)
- AUPH 1.1M
- VTEX 777.8K
- Earning Date
- AUPH 05-12-2025
- VTEX 05-06-2025
- Dividend Yield
- AUPH N/A
- VTEX N/A
- EPS Growth
- AUPH N/A
- VTEX N/A
- EPS
- AUPH 0.27
- VTEX 0.07
- Revenue
- AUPH $247,295,000.00
- VTEX $228,237,000.00
- Revenue This Year
- AUPH $11.86
- VTEX $14.89
- Revenue Next Year
- AUPH $24.96
- VTEX $16.64
- P/E Ratio
- AUPH $29.71
- VTEX $89.77
- Revenue Growth
- AUPH 29.20
- VTEX 7.72
- 52 Week Low
- AUPH $4.98
- VTEX $4.20
- 52 Week High
- AUPH $10.67
- VTEX $8.24
- Technical
- Relative Strength Index (RSI)
- AUPH 44.68
- VTEX 72.77
- Support Level
- AUPH $7.89
- VTEX $5.24
- Resistance Level
- AUPH $8.49
- VTEX $6.15
- Average True Range (ATR)
- AUPH 0.30
- VTEX 0.22
- MACD
- AUPH -0.02
- VTEX 0.11
- Stochastic Oscillator
- AUPH 36.95
- VTEX 88.73
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.